Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
With advances in new therapies that target airway inflammation, there is an urgent need for accurate and easy-to-use biomarkers to predict asthma exacerbations and likely patient responses to treatment. Blood and sputum eosinophilia are used to predict the response of patients with asthma to steroi...
Những tác giả chính: | , , , , , , , , , , , |
---|---|
Định dạng: | Conference item |
Được phát hành: |
BMJ Publishing Group
2017
|